Corcept Therapeutics Inc (CORT)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

149 COMMONWEALTH DRIVE MENLO PARK, CA 94025

Corcept is a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and psychiatric disorders by modulating the effects of the hormone cortisol. Korlym® was the first drug approved by the U.S. Food and Drug Administration for patients with Cushing's syndrome. Corcept has discovered a large portfolio of proprietary compounds that selectively modulate the effects of cortisol. The company owns extensive United States and foreign intellectual property covering the composition of its selective cortisol modulators and the use of cortisol modulators to treat a variety of serious disorders.

Data as of 2021-08-02 07:52:33 -0400
Market Cap2.408 Billion Shares Outstanding115.927 Million Avg 30-day Volume513.311 Thousand
P/E Ratio24.66827 Dividend Yield EPS0.769
Price/Sales7.02 Debt to Equity1.09 EBITDA110.184 Million
Price to Book Value4.61 Forward PE0.19 Enterprise Value2.038 Billion
Total Cash369.982 Million Current Debt45.402 Million Gross Profit337.965 Million
BETA1.21934 52-week High/Low31.18 / 12.2 Next Earnings Date2021-08-03 Price to Cash FLow (P/CF) 109.9625
Data provided by IEX Cloud
View SEC Filings from CORT instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 2 7 -71.43% 1 (0.06%) 3 (0.17%) -66.67%
Funds Holding: 206 226 -8.85% 50 (2.93%) 57 (3.31%) -12.28%
13F shares: 80.55 Million 83.369 Million -3.38% 25.357 Million 27.68 Million -8.39%
% Ownership 68.663 71.7625 -4.32% 21.6153 23.8263 -9.28%
New Positions: 21 35 -40.0% 8 9 -11.11%
Increased Positions 62 60 3.33% 14 13 7.69%
Closed Positions 38 32 18.75% 14 20 -30.0%
Reduced Positions 86 93 -7.53% 24 30 -20.0%
Total Calls 491.065 Thousand 863.418 Thousand -43.13% 118 Thousand 146.5 Thousand -19.45%
Total Puts 471.377 Thousand 1.153 Million -59.13% 215.2 Thousand 461.5 Thousand -53.37%
PUT/CALL Ratio 0.96 1.34 -28.36% 1.82 3.15 -42.22%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Corcept Therapeutics Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding CORT (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CORT BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

150 Thousand total shares from 2 transactions

Open Market Sells (S)

50 Thousand total shares from 2 transactions

Exercise Derivative Conversion (M)

110 Thousand total shares from 4 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MADUCK SEAN CHIEF COMMERCIAL OFFICER

  • Officer
 232,626 2021-08-03 5

HUNT HAZEL CHIEF SCIENTIFIC OFFICER

  • Officer
 38,493 2021-07-14 3

MURRAY JOSHUA M.

  • Director
 60,000 2021-07-01 2

BAKER G LEONARD JR

  • Director
 5,310,196 2021-06-11 12

SWISHER DANIEL N JR

  • Director
 35,000 2021-06-02 5

WILSON JAMES N

  • Director
 45,000 2021-05-26 3

MAHONEY DAVID L

  • Director
 20,000 2021-05-26 2

PARK KIMBERLY

  • Director
 20,000 2021-05-26 1

ALTON GREGG H

  • Director
 20,000 2021-05-26 1

CANNON GILLIAN

  • Director
 20,000 2021-05-26 3

ROBB GARY CHARLES CHIEF FINANCIAL OFFICER

  • Officer
 89,330 2021-04-23 6

LYON JOSEPH DOUGLAS CHIEF ACCOUNTING OFFICER

  • Officer
 75,000 2021-04-01 5

MOKARI ATABAK CHIEF FINANCIAL OFFICER

  • Officer
 400,000 2021-03-01 2

BELANOFF JOSEPH K CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
 0 2021-02-05 2

GRAUER ANDREAS CHIEF MEDICAL OFFICER

  • Officer
 0 2021-02-05 1

BRADBURY DANIEL

  • Director
 130,575 2019-02-07 0

FISHMAN ROBERT S CHIEF MEDICAL OFFICER

  • Officer
 0 2018-11-07 0

GALA RENEE D

  • Director
 0 2018-08-20 0

ENRIGHT PATRICK G

  • Director
 6,108,328 2017-03-16 0

TAMMENOMS BAKKER JULIET

  • 10% Owner
 No longer subject to file 2016-12-15 0

LONGITUDE VENTURE PARTNERS L.P.

LONGITUDE CAPITAL PARTNERS, LLC

TAMMENOMS BAKKER JULIET

LONGITUDE CAPITAL ASSOCIATES, L.P.

  • 10% Owner
 No longer subject to file 2016-11-28 0

LO STEVEN SVP ONCOLOGY

  • Officer
 585,416 2015-11-16 0

LEDOUX ANNE M VP & CONTROLLER

  • Officer
 50,000 2015-09-28 0

COOK JOSEPH C JR

  • Director
 0 2015-06-18 0

TURNER JOSEPH L

  • Director
 0 2015-06-18 0

ROE ROBERT L PRESIDENT AND SECRETARY

  • Officer
 0 2013-01-30 0

PULLARA SAMUEL J III

  • 10% Owner
 5,420,353 2012-11-01 0

DYCKERHOFF STEFAN A

  • 10% Owner
 5,420,353 2012-11-01 0

YOUNGER WILLIAM H JR

  • 10% Owner
 6,333,759 2012-08-14 0

WHITE JAMES N

  • 10% Owner
 266,781 2012-03-29 0

SWEET DAVID E

  • 10% Owner
 65,989 2012-03-29 0

SPEISER MICHAEL L

  • 10% Owner
 13,399 2012-03-29 0

SHEEHAN ANDREW T

  • 10% Owner
 40,079 2012-03-29 0

GAITHER JAMES C

  • 10% Owner
 124,908 2012-03-29 0

COXE TENCH

  • 10% Owner
 1,470,150 2012-03-29 0

BIRD JEFFREY W

  • 10% Owner
 242,210 2012-03-29 0

ANDERSON DAVID L

  • 10% Owner
 1,000,376 2012-03-29 0

SUTTER HILL VENTURES

WHITE JAMES N

  • 10% Owner
 5,316,967 2012-03-29 0

SUTTER HILL VENTURES

BAKER G LEONARD JR

ANDERSON DAVID L

YOUNGER WILLIAM H JR

COXE TENCH

GAITHER JAMES C

SWEET DAVID E

SHEEHAN ANDREW T

SPEISER MICHAEL L

BIRD JEFFREY W

  • Director
  • 10% Owner
 5,316,967 2012-03-29 0

SANDS GREGORY P

  • 10% Owner
 193,156 2011-10-21 0

SUTTER HILL VENTURES

BIRD JEFFREY W

WHITE JAMES N

  • 10% Owner
 5,036,602 2011-10-21 0

SUTTER HILL VENTURES

BAKER G LEONARD JR

ANDERSON DAVID L

YOUNGER WILLIAM H JR

COXE TENCH

SANDS GREGORY P

GAITHER JAMES C

SWEET DAVID E

SHEEHAN ANDREW T

SPEISER MICHAEL L

  • Director
  • 10% Owner
 5,036,602 2011-10-21 0

HARPER JAMES A

  • Director
 67,400 2010-06-23 0

PENHOET EDWARD

  • 10% Owner
 5,705,517 2010-04-05 0

ALTA BIOPHARMA PARTNERS II LP

ALTA BIOPHARMA MANAGEMENT II LLC

ALTA EMBARCADERO BIOPHARMA PARTNERS II LLC

ALTA PARTNERS II INC

DELEAGE JEAN

CHAMPSI FARAH

  • 10% Owner
 5,664,267 2009-10-16 0

PAPERBOY VENTURES, LLC

  • Director
 209,694 2009-05-07 0

ANDERSSON ALLEN

  • Director
 306,837 2009-05-07 0

SUTTER HILL VENTURES

  • 10% Owner
 4,338,742 2009-02-06 0

LOEWY CAROLINE M CHIEF FINANCIAL OFFICER

  • Officer
 0 2008-11-28 0

ALTA BIOPHARMA PARTNERS II LP

MARDUEL ALIX

DELEAGE JEAN

CHAMPSI FARAH

ALTA BIOPHARMA MANAGEMENT II LLC

ALTA EMBARCADERO BIOPHARMA PARTNERS II LLC

ALTA PARTNERS II INC

  • 10% Owner
 5,314,616 2008-11-11 0

ALTA BIOPHARMA PARTNERS II LP

ALTA CALIFORNIA MANAGEMENT PARTNERS II LLC

ALTA EMBARCADERO PARTNERS II LLC

DELEAGE JEAN

CHAMPSI FARAH

ALTA PARTNERS II INC

  • 10% Owner
 5,209,790 2008-03-25 0

MARDUEL ALIX

  • Director
  • 10% Owner
 5,209,790 2008-03-25 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

MADUCK SEAN - Officer CHIEF COMMERCIAL OFFICER

2021-08-05 17:30:36 -0400 2021-08-03 M 25,000 $3.29 a 65,024 direct yes

MADUCK SEAN - Officer CHIEF COMMERCIAL OFFICER

2021-08-05 17:30:36 -0400 2021-08-03 M 25,000 d 172,602 direct yes

MADUCK SEAN - Officer CHIEF COMMERCIAL OFFICER

2021-08-05 17:30:36 -0400 2021-08-03 S 25,000 $21.18 d 40,024 direct yes

HUNT HAZEL - Officer CHIEF SCIENTIFIC OFFICER

2021-07-16 17:14:28 -0400 2021-07-14 M 50,000 $2.89 a 68,975 direct -0.3406 -1.9951 0.9732 3 -1.9951 6

HUNT HAZEL - Officer CHIEF SCIENTIFIC OFFICER

2021-07-16 17:14:28 -0400 2021-07-14 M 50,000 d 0 direct

HUNT HAZEL - Officer CHIEF SCIENTIFIC OFFICER

2021-07-16 17:14:28 -0400 2021-07-14 F 30,482 $20.59 d 38,493 direct -0.3406 -1.9951 0.9732 3 -1.9951 6

MADUCK SEAN - Officer CHIEF COMMERCIAL OFFICER

2021-07-14 17:08:08 -0400 2021-07-13 M 10,000 d 15,000 direct

MADUCK SEAN - Officer CHIEF COMMERCIAL OFFICER

2021-07-14 17:08:08 -0400 2021-07-13 M 10,000 $2.24 a 40,024 direct -0.7859 -0.1965 1.9155 5 -0.7859 2

MADUCK SEAN - Officer CHIEF COMMERCIAL OFFICER

2021-07-09 17:29:28 -0400 2021-07-07 M 25,000 d 197,602 direct yes

MADUCK SEAN - Officer CHIEF COMMERCIAL OFFICER

2021-07-09 17:29:28 -0400 2021-07-07 S 25,000 $22.19 d 30,024 direct yes -1.0092 -5.7339 0.0 1 -7.3394 5

MADUCK SEAN - Officer CHIEF COMMERCIAL OFFICER

2021-07-09 17:29:28 -0400 2021-07-07 M 25,000 $3.29 a 55,024 direct yes -1.0092 -5.7339 0.0 1 -7.3394 5

MURRAY JOSHUA M. - Director

2021-07-02 17:12:18 -0400 2021-07-01 A 60,000 a 60,000 direct

BAKER G LEONARD JR - Director

2021-06-15 19:01:42 -0400 2021-06-11 P 50,000 $21.53 a 1,046,838 direct 0.745 -2.454 -11.0868 0.745 2 -12.2699 29

BAKER G LEONARD JR - Director by ltd partnership

2021-06-15 19:01:42 -0400 2021-06-11 P 100,000 $21.53 a 3,308,303 indirect 0.745 -2.454 -11.0868 0.745 2 -12.2699 29

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CORCEPT THERAPEUTICS INC CORT 2021-08-05 22:15:04 UTC -0.3065 0.3865 2600000
CORCEPT THERAPEUTICS INC CORT 2021-08-05 21:45:03 UTC -0.3065 0.3865 2600000
CORCEPT THERAPEUTICS INC CORT 2021-08-05 21:15:03 UTC -0.3065 0.3865 2600000
CORCEPT THERAPEUTICS INC CORT 2021-08-05 20:45:03 UTC -0.3065 0.3865 2600000
CORCEPT THERAPEUTICS INC CORT 2021-08-05 20:15:04 UTC -0.3065 0.3865 2600000
CORCEPT THERAPEUTICS INC CORT 2021-08-05 19:45:04 UTC -0.3065 0.3865 2600000
CORCEPT THERAPEUTICS INC CORT 2021-08-05 19:15:03 UTC -0.3065 0.3865 2600000
CORCEPT THERAPEUTICS INC CORT 2021-08-05 18:45:03 UTC -0.17 0.25 2600000
CORCEPT THERAPEUTICS INC CORT 2021-08-05 18:15:03 UTC -0.17 0.25 2600000
CORCEPT THERAPEUTICS INC CORT 2021-08-05 17:45:03 UTC -0.17 0.25 2600000
CORCEPT THERAPEUTICS INC CORT 2021-08-05 17:15:03 UTC -0.17 0.25 2600000
CORCEPT THERAPEUTICS INC CORT 2021-08-05 16:45:02 UTC -0.17 0.25 2600000
CORCEPT THERAPEUTICS INC CORT 2021-08-05 16:15:03 UTC -0.17 0.25 2600000
CORCEPT THERAPEUTICS INC CORT 2021-08-05 15:45:03 UTC -0.17 0.25 2600000
CORCEPT THERAPEUTICS INC CORT 2021-08-05 15:15:02 UTC -0.17 0.25 2600000
CORCEPT THERAPEUTICS INC CORT 2021-08-05 14:45:02 UTC -0.17 0.25 2600000
CORCEPT THERAPEUTICS INC CORT 2021-08-05 14:15:04 UTC -0.17 0.25 2600000
CORCEPT THERAPEUTICS INC CORT 2021-08-05 13:45:04 UTC -0.17 0.25 2600000
CORCEPT THERAPEUTICS INC CORT 2021-08-05 13:15:03 UTC -0.17 0.25 2600000
CORCEPT THERAPEUTICS INC CORT 2021-08-05 12:45:03 UTC -0.17 0.25 2600000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund CORT -100.0 shares, $-2379.0 2021-03-31 N-PORT

Elevate your investments